U.S. markets closed

Bayer Aktiengesellschaft (BAYN.SW)

Swiss - Swiss Delayed Price. Currency in USD
Add to watchlist
67.990.00 (0.00%)
At close: 4:53PM CEST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
49 214 30 1

IndustryDrug Manufacturers—General
Full Time Employees100,618

Key Executives

NameTitlePayExercisedYear Born
Mr. Werner BaumannChairman of Management Board, CEO, Labor Director & Chief Sustainability OfficerN/AN/A1962
Mr. Wolfgang U. NicklCFO & Member of Management BoardN/AN/A1969
Mr. Liam CondonMember of Management Board & Pres of Bayer Crop Science DivisionN/AN/A1968
Mr. Heiko W. J. SchipperHead of Consumer Health Division & Member of Management BoardN/AN/A1969
Mr. Stefan OelrichPres of Pharmaceuticals Division & Member of the Board of ManagementN/AN/A1968
Mr. Bernd-Peter BierHead of Accounting and Head of TaxesN/AN/A1967
Mr. Oliver MaierHead of Investor RelationsN/AN/AN/A
Dr. Gabriel HarnierHead of Law, Patents & ComplianceN/AN/A1971
Mr. Michael PreussHead of Communications, Gov. Relations and Corp. BrandN/AN/AN/A
Mr. James TurnerGlobal Product DirectorN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in .


Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center at the University of Texas to develop cancer treatments; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. It has strategic research alliance with Kyoto University, Sensyne Health plc, and Atomwise Inc. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Corporate Governance

Bayer Aktiengesellschaft’s ISS Governance QualityScore as of November 1, 2019 is 4. The pillar scores are Audit: 10; Board: 3; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.